AP control of as the most efficacious tool for the prevention of cardiovascular complications in patients with type 2 diabetes mellitus
Эксперты прогнозируют значительный рост заболеваемости СД2 в ближайшие 10?15 лет. Неблагоприятный прогноз у этих больных определяется высоким риском развития кардио- и цереброваскулярных осложнений. Применение фиксированной комбинации периндоприла с индапамидом (нолипрел) у больных СД2 независимо от...
Saved in:
| Main Author: | Yury Alexandrovich Karpov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2009-06-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Markers for the Assessment of Microvascular Complications in Patients with Metabolic Syndrome
by: Diana Nikolova, et al.
Published: (2025-03-01) -
ROLE OF TLR2, TLR4 GENE POLYMORPHISM IN DEVELOPING MICROVASCULAR COMPLICATIONS IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
by: A. A. Voropai, et al.
Published: (2021-10-01) -
Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes
by: Hamidullah, et al.
Published: (2024-07-01) -
Unveiling biomarkers via plasma metabolome profiling for diabetic macrovascular and microvascular complications
by: Zhixi Li, et al.
Published: (2025-08-01) -
Fibrinogen-to-albumin ratio (FAR) for predicting microvascular flap complications in reconstructive surgery
by: Rihards Peteris Rocans, et al.
Published: (2025-06-01)